Popular weight-loss and diabetes medications like Ozempic are doing far more than helping people shed kilograms; they are actively changing how the brain handles cravings and balancing severe hormonal disorders.

Speaking on The Discourse, Dr Melanie Cree from the University of Colorado explained that brain scans show these GLP-1 drugs actually improve communication between the brain’s calorie center and its emotional center. This medical shift effectively shuts down constant hunger signals, silencing what patients describe as “food noise.”

The medication has also shown massive promise for young women living with Polycystic Ovarian Syndrome, recently renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). Women with PMOS suffer from high testosterone, causing irregular periods and facial hair.

Cree’s research revealed that the drug successfully lowers this male hormone, causing these distressing symptoms to clear up. While the medication is also linked to lower risks of heart disease and certain cancers, Cree warned that patients must balance these benefits against common, harsh side effects like severe nausea, vomiting, and dehydration.

–ChannelAfrica–